Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Ssebambulidde

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Medical Mycology|October 17, 2024
Clinical importance of cerebrospinal fluid protein levels in HIV-associated cryptococcal meningitis: Insights from a prospective cohort study in UgandaJohn Kasibante, Eesha Irfanullah, Abduljewad Wele, et al.
Medrxiv : the Preprint Server for Health Sciences|January 3, 2024
Utility of Cerebrospinal Fluid Protein Levels as a Potential Predictive Biomarker of Disease Severity in HIV-Associated Cryptococcal MeningitisJohn Kasibante, Eesha Irfanullah, Abduljewad Wele, et al.
Medical Mycology|January 8, 2025
The evolution of HIV-associated cryptococcal meningitis in Uganda from 2010 to 2022Stewart Walukaga, Ann Fieberg, Abdu Musubire, et al.
Open Forum Infectious Diseases|May 7, 2020
Standardized Urine-Based Tuberculosis (TB) Screening With TB-Lipoarabinomannan and Xpert MTB/RIF Ultra in Ugandan Adults With Advanced Human Immunodeficiency Virus Disease and Suspected MeningitisFiona V Cresswell, Jayne Ellis, Enock Kagimu, et al.
Science Advances|March 21, 2025
Pathway-instructed therapeutic selection of ruxolitinib reduces neuroinflammation in fungal postinfectious inflammatory syndromeJessica C Hargarten, Kenneth Ssebambulidde, Seher H Anjum, et al.
The American Journal of Tropical Medicine and Hygiene|October 7, 2020
Hepatitis B Awareness and Vaccination Patterns among Healthcare Workers in AfricaShemal M Shah, Holly Rodin, Hope Pogemiller, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 20, 2022
Outpatient Cryptococcal Antigen Screening Is Associated With Favorable Baseline Characteristics and Improved Survival in Persons With Cryptococcal Meningitis in UgandaAnna E Levin, Ananta S Bangdiwala, Elizabeth Nalintya, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 9, 2020
Cerebrospinal Fluid Early Fungicidal Activity as a Surrogate Endpoint for Cryptococcal Meningitis Survival in Clinical TrialsMatthew F Pullen, Katherine Huppler Hullsiek, Joshua Rhein, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 22, 2023
Oral Lipid Nanocrystal Amphotericin B for Cryptococcal Meningitis: A Randomized Clinical TrialDavid R Boulware, Mucunguzi Atukunda, Enock Kagimu, et al.
The New England Journal of Medicine|March 23, 2022
Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal MeningitisJoseph N Jarvis, David S Lawrence, David B Meya, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Medical Mycology|October 17, 2024
Clinical importance of cerebrospinal fluid protein levels in HIV-associated cryptococcal meningitis: Insights from a prospective cohort study in UgandaJohn Kasibante, Eesha Irfanullah, Abduljewad Wele, et al.
Medrxiv : the Preprint Server for Health Sciences|January 3, 2024
Utility of Cerebrospinal Fluid Protein Levels as a Potential Predictive Biomarker of Disease Severity in HIV-Associated Cryptococcal MeningitisJohn Kasibante, Eesha Irfanullah, Abduljewad Wele, et al.
Medical Mycology|January 8, 2025
The evolution of HIV-associated cryptococcal meningitis in Uganda from 2010 to 2022Stewart Walukaga, Ann Fieberg, Abdu Musubire, et al.
Open Forum Infectious Diseases|May 7, 2020
Standardized Urine-Based Tuberculosis (TB) Screening With TB-Lipoarabinomannan and Xpert MTB/RIF Ultra in Ugandan Adults With Advanced Human Immunodeficiency Virus Disease and Suspected MeningitisFiona V Cresswell, Jayne Ellis, Enock Kagimu, et al.
Science Advances|March 21, 2025
Pathway-instructed therapeutic selection of ruxolitinib reduces neuroinflammation in fungal postinfectious inflammatory syndromeJessica C Hargarten, Kenneth Ssebambulidde, Seher H Anjum, et al.
The American Journal of Tropical Medicine and Hygiene|October 7, 2020
Hepatitis B Awareness and Vaccination Patterns among Healthcare Workers in AfricaShemal M Shah, Holly Rodin, Hope Pogemiller, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 20, 2022
Outpatient Cryptococcal Antigen Screening Is Associated With Favorable Baseline Characteristics and Improved Survival in Persons With Cryptococcal Meningitis in UgandaAnna E Levin, Ananta S Bangdiwala, Elizabeth Nalintya, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 9, 2020
Cerebrospinal Fluid Early Fungicidal Activity as a Surrogate Endpoint for Cryptococcal Meningitis Survival in Clinical TrialsMatthew F Pullen, Katherine Huppler Hullsiek, Joshua Rhein, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 22, 2023
Oral Lipid Nanocrystal Amphotericin B for Cryptococcal Meningitis: A Randomized Clinical TrialDavid R Boulware, Mucunguzi Atukunda, Enock Kagimu, et al.
The New England Journal of Medicine|March 23, 2022
Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal MeningitisJoseph N Jarvis, David S Lawrence, David B Meya, et al.
Pageof 8